InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...
Global measles cases surged by more than 20% to an estimated 10.3 million last year, the World Health Organization and the US Centers for Disease Control and Prevention said Thursday.